BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27183981)

  • 1. Recent Trends in the Discovery of Small Molecule Blockers of Sodium Channels.
    Gualdani R; Cavalluzzi MM; Lentini G
    Curr Med Chem; 2016; 23(22):2289-332. PubMed ID: 27183981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in targeting voltage-gated sodium channels with small molecules.
    Nardi A; Damann N; Hertrampf T; Kless A
    ChemMedChem; 2012 Oct; 7(10):1712-40. PubMed ID: 22945552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activity.
    Green BR; Bulaj G; Norton RS
    Future Med Chem; 2014 Oct; 6(15):1677-98. PubMed ID: 25406007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voltage-gated Sodium Channels and Blockers: An Overview and Where Will They Go?
    Li ZM; Chen LX; Li H
    Curr Med Sci; 2019 Dec; 39(6):863-873. PubMed ID: 31845216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in sodium channel modulators for pain.
    Bagal SK; Chapman ML; Marron BE; Prime R; Storer RI; Swain NA
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3690-9. PubMed ID: 25060923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voltage gated sodium channels as drug discovery targets.
    Bagal SK; Marron BE; Owen RM; Storer RI; Swain NA
    Channels (Austin); 2015; 9(6):360-6. PubMed ID: 26646477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium channel blockers for neuropathic pain.
    Zuliani V; Rivara M; Fantini M; Costantino G
    Expert Opin Ther Pat; 2010 Jun; 20(6):755-79. PubMed ID: 20384535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conotoxin modulation of voltage-gated sodium channels.
    Ekberg J; Craik DJ; Adams DJ
    Int J Biochem Cell Biol; 2008; 40(11):2363-8. PubMed ID: 17951097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the medicinal chemistry of sodium channel blockers and their therapeutic potential.
    Zuliani V; Patel MK; Fantini M; Rivara M
    Curr Top Med Chem; 2009; 9(4):396-415. PubMed ID: 19442209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voltage-gated sodium channels: mutations, channelopathies and targets.
    Andavan GS; Lemmens-Gruber R
    Curr Med Chem; 2011; 18(3):377-97. PubMed ID: 21143119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the modulation of voltage-gated ion channels for the treatment of epilepsy.
    Cosford ND; Meinke PT; Stauderman KA; Hess SD
    Curr Drug Targets CNS Neurol Disord; 2002 Feb; 1(1):81-104. PubMed ID: 12769636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protonation state of inhibitors determines interaction sites within voltage-gated sodium channels.
    Buyan A; Sun D; Corry B
    Proc Natl Acad Sci U S A; 2018 Apr; 115(14):E3135-E3144. PubMed ID: 29467289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders.
    Mantegazza M; Curia G; Biagini G; Ragsdale DS; Avoli M
    Lancet Neurol; 2010 Apr; 9(4):413-24. PubMed ID: 20298965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Voltage-Gated Sodium Channel Ligands: Biosynthesis and Biology.
    Lukowski AL; Narayan ARH
    Chembiochem; 2019 May; 20(10):1231-1241. PubMed ID: 30605564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent current blockers of voltage-gated sodium channels: a clinical opportunity for controlling metastatic disease.
    Djamgoz MB; Onkal R
    Recent Pat Anticancer Drug Discov; 2013 Jan; 8(1):66-84. PubMed ID: 23116083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecules targeting sodium and calcium channels for neuropathic pain.
    Bear B; Asgian J; Termin A; Zimmermann N
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):543-61. PubMed ID: 19562650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voltage gated sodium channels in cancer and their potential mechanisms of action.
    Angus M; Ruben P
    Channels (Austin); 2019 Dec; 13(1):400-409. PubMed ID: 31510893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical basis of specificity and delayed binding of a subtype selective sodium channel inhibitor.
    Corry B
    Sci Rep; 2018 Jan; 8(1):1356. PubMed ID: 29358762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacology of voltage-gated sodium channels in sensory neurones.
    Docherty RJ; Farmer CE
    Handb Exp Pharmacol; 2009; (194):519-61. PubMed ID: 19655117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand- and structure-based virtual screening for clathrodin-derived human voltage-gated sodium channel modulators.
    Tomašić T; Hartzoulakis B; Zidar N; Chan F; Kirby RW; Madge DJ; Peigneur S; Tytgat J; Kikelj D
    J Chem Inf Model; 2013 Dec; 53(12):3223-32. PubMed ID: 24215100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.